The Impact of Recurrent Clostridium difficile Infection on Patients' Prevention Behaviors

被引:9
|
作者
Weaver, Frances M. [1 ,2 ]
Trick, William E. [3 ]
Evans, Charlesnika T. [2 ,4 ]
Lin, Michael Y. [5 ,6 ]
Adams, William [7 ]
Pho, Mai T. [8 ]
Bleasdale, Susan C. [9 ,10 ]
Mullane, Kathleen M. [8 ]
Johnson, Stuart [11 ,12 ,13 ]
Sikka, Monica K. [9 ,10 ]
Peterson, Lance R. [14 ]
Solomonides, Anthony E. [15 ,16 ]
Gerding, Dale N. [17 ]
机构
[1] Loyola Univ, Publ Hlth Sci, Chicago, IL 60611 USA
[2] Hines Vet Affairs Hosp, Ctr Innovat Complex Chron Healthcare CINCCH, Hines, IL USA
[3] Rush Univ, Dept Med, Cook Cty Hlth & Hosp Syst, Med Ctr, Chicago, IL 60612 USA
[4] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA
[5] Northwestern Univ, Ctr Hlth Care Studies, Inst Publ Hlth & Med, Chicago, IL 60611 USA
[6] Rush Univ, Med Ctr, Div Infect Dis, Chicago, IL 60612 USA
[7] Loyola Univ, Hlth Sci Div, Maywood, IL 60153 USA
[8] Univ Chicago, Dept Med, Div Infect Dis & Global Hlth, Chicago, IL 60637 USA
[9] Univ Illinois, Coll Med, Div Infect Dis, Chicago, IL USA
[10] Jesse Brown Vet Affairs Med Ctr, Dept Med, Chicago, IL USA
[11] Loyola Univ Med Ctr, Div Infect Dis, Chicago, IL USA
[12] Edward Hines Jr Vet Affairs Hosp, Res Serv, Hines, IL USA
[13] Edward Hines Jr Vet Affairs Hosp, Infect Dis Sect, Hines, IL USA
[14] NorthShore Univ Hlth Syst, Dept Clin Microbiol & Infect Dis, Evanston, IL USA
[15] NorthShore Univ Hlth Syst, Dept Family Med, Evanston, IL USA
[16] NorthShore Univ Hlth Syst, Ambulatory Primary Care Innovat Grp, Evanston, IL USA
[17] Edward Hines Jr Vet Affairs Hosp, Hines, IL USA
关键词
ECONOMIC BURDEN; RISK; EPIDEMIOLOGY; METAANALYSIS; PROBIOTICS; SOCIETY; COHORT;
D O I
10.1017/ice.2017.208
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE To determine the impact of recurrent Clostridium difficile infection (RCDI) on patient behaviors following illness. METHODS Using a computer algorithm, we searched the electronic medical records of 7 Chicago-area hospitals to identify patients with RCDI (2 episodes of CDI within 15 to 56 days of each other). RCDI was validated by medical record review. Patients were asked to complete a telephone survey. The survey included questions regarding general health, social isolation, symptom severity, emotional distress, and prevention behaviors. RESULTS In total, 119 patients completed the survey (32%). On average, respondents were 57.4 years old (standard deviation, 16.8); 57% were white, and similar to 50% reported hospitalization for CDI. At the time of their most recent illness, patients rated their diarrhea as high severity (58.5%) and their exhaustion as extreme (30.7%). Respondents indicated that they were very worried about getting sick again (41.5%) and about infecting others (31%). Almost 50% said that they have washed their hands more frequently (47%) and have increased their use of soap and water (45%) since their illness. Some of these patients (22%-32%) reported eating out less, avoiding certain medications and public areas, and increasing probiotic use. Most behavioral changes were unrelated to disease severity. CONCLUSION Having had RCDI appears to increase prevention-related behaviors in some patients. While some behaviors are appropriate (eg, handwashing), others are not supported by evidence of decreased risk and may negatively impact patient quality of life. Providers should discuss appropriate prevention behaviors with their patients and should clarify that other behaviors (eg, eating out less) will not affect their risk of future illness. Infect Control Hosp Epidemiol. 2017;38:1351-1357
引用
收藏
页码:1351 / 1357
页数:7
相关论文
共 50 条
  • [31] Prevention of Clostridium difficile Infection: A Systematic Survey of Clinical Practice Guidelines
    Lytvyn, Lyubov
    Mertz, Dominik
    Sadeghirad, Behnam
    Alaklobi, Faisal
    Selva, Anna
    Alonso-Coello, Pablo
    Johnston, Bradley C.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (08) : 901 - 908
  • [32] Prevention of Clostridium difficile Infection in Critically Ill Adults
    Leedahl, David D.
    Personett, Heather A.
    Nagpal, Avish
    Barreto, Erin F.
    PHARMACOTHERAPY, 2019, 39 (03): : 399 - 407
  • [33] Consensus on the prevention, diagnosis, and treatment of Clostridium difficile infection
    Abreu y Abreu, A. T.
    Velarde-Ruiz Velasco, J. A.
    Zavala-Solares, M. R.
    Remes-Troche, J. M.
    Carmona-Sanchez, R. I.
    Aldana-Ledesma, J. M.
    Camacho-Ortiz, A.
    Contreras-Omana, R.
    Diaz-Seoane, R.
    Elizondo-Vazquez, C. T.
    Garza-Gonzalez, E.
    Grajales-Figueroa, G.
    Gomez-Escudero, O.
    Jacobo-Karam, J. S.
    Morales-Arambula, M.
    Olivares-Guzman, L. O.
    Sifuentes-Osornio, J.
    Siu-Moguel, A. G.
    Soto-Solis, R.
    Valdovinos-Garcia, L. R.
    Valdovinos-Diaz, M. A.
    Vazquez-Elizondo, G.
    la Vega Jasso, S. A. Lazo-de
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2019, 84 (02): : 204 - 219
  • [34] Impact of Clostridium Difficile Infection in a Rehabilitation Unit
    Orini, S.
    Lecchi, C.
    Mule, C.
    Maestri, A.
    Astolfi, N.
    Taveggia, G.
    17TH ESPRM EUROPEAN CONGRESS OF PHYSICAL AND REHABILITATION MEDICINE, 2010, : 104 - 108
  • [35] Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain
    Salavert, Miguel
    Cobo, Javier
    Pascual, Alvaro
    Aragon, Belen
    Maratia, Stefano
    Jiang, Yiling
    Aceituno, Susana
    Grau, Santiago
    ADVANCES IN THERAPY, 2018, 35 (11) : 1920 - 1934
  • [36] Common Questions About Clostridium difficile Infection
    Winslow, Bradford T.
    Onysko, Mary
    Thompson, Kathleen A.
    Caldwell, Katharine
    Ehlers, Gordon H.
    AMERICAN FAMILY PHYSICIAN, 2014, 89 (06) : 437 - 442
  • [37] Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection With a Focus on Immunocompromised Patients
    Askar, Sally F.
    Kenney, Rachel M.
    Tariq, Zain
    Conner, Ruth
    Williams, Jonathan
    Ramesh, Mayur
    Alangaden, George J.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (03) : 584 - 587
  • [38] Probiotics in Clostridium difficile Infection
    Na, Xi
    Kelly, Ciaran
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 : S154 - S158
  • [39] Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection
    Hamilton, Matthew J.
    Weingarden, Alexa R.
    Sadowsky, Michael J.
    Khoruts, Alexander
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (05) : 761 - 767
  • [40] Prevalence of Clostridium Difficile Infection in Patients After Radical Cystectomy and Neoadjuvant Chemotherapy
    Cotter, Katherine J.
    Fan, Yunhua
    Sieger, Gretchen K.
    Weight, Christopher J.
    Konety, Badrinath R.
    BLADDER CANCER, 2017, 3 (04) : 305 - 310